Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Neuropace Inc NPCE

Healthcare Medical Devices
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable... see more

Current News (NDAQ:NPCE)

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting

Business Wire 4 days ago

NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services

Business Wire 12 days ago

NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Business Wire November 4, 2025

NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025

Business Wire October 22, 2025

NeuroPace to Participate in Upcoming Healthcare Conferences

Business Wire August 28, 2025

NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

GlobeNewswire August 12, 2025

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases

GlobeNewswire August 1, 2025

NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

GlobeNewswire July 29, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

GlobeNewswire July 6, 2025
View More News ››

Opinion & Analysis (NDAQ:NPCE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NPCE)

NeuroPace, Inc. (NPCE): Driving Growth and Expanding Access

http://beyondspx.com/2024/08/01/neuropace-inc-npce-driving-growth-and-expanding-access-to-transformative-epilepsy-treatment/
MikeTester - August 2, 2024

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

<< View Post To Watch Video >>
CoressPrings - November 18, 2021

🎉📣FSD Pharma's Research and Clinical Advisory Board📢

Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical...
CoressPrings - November 17, 2021

📣FSD Pharma:Agreement Signed With Covar Pharmaceuticals📢📣

<< View Post To Watch Video >>
CoressPrings - November 10, 2021

📢📣FSD Pharma forms agreement with Covar Pharmaceuticals 📢

<< View Post To Watch Video >>
CoressPrings - October 30, 2021
View more Bullboard ››

Vista Gold Corp.

Vista Gold Corp.

Vista Gold holds the Mt Todd gold project, a leading development-stage gold deposit located in the Tier-1 mining jurisdiction ...
View More »